Crossref
FDA Greenlights First Over-the-Counter Oral Birth Control
JAMA · 2023
DOI: 10.1001/jama.2023.13131 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2023. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Contraception, Nonprescription Drugs, Contraceptives, Oral, Drug Approval. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
ContraceptionNonprescription DrugsContraceptives, OralDrug ApprovalUnited StatesUnited States Food and Drug Administration
Substanzen
Nonprescription DrugsContraceptives, Oral
Zitieren
APA
Harris, E. (2023). FDA Greenlights First Over-the-Counter Oral Birth Control. JAMA. https://doi.org/10.1001/jama.2023.13131
Vancouver
Harris E. FDA Greenlights First Over-the-Counter Oral Birth Control. JAMA. 2023. doi:10.1001/jama.2023.13131
BibTeX
@article{Harris2023,
author = {Harris, Emily},
title = {FDA Greenlights First Over-the-Counter Oral Birth Control},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.13131}
}
EUVIMED